Atlas Trials

Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

Clinical trial NCT04472806 · UNKNOWN

Trial details

NCT number
NCT04472806
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Mucosal Melanoma
Start date
2020-06-20
Primary completion
2022-06-20
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.